The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial

Abstract Background Leukotriene receptor antagonists (LTRAs) are broadly used for the management of allergic asthma and have recently been indicated to inhibit carcinogenesis and cancer cell growth. In colorectal cancer (CRC) chemoprevention studies, the occurrence of adenoma or CRC itself is genera...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Takuma Higurashi, Jun Arimoto, Keiichi Ashikari, Tomohiro Takatsu, Noboru Misawa, Tsutomu Yoshihara, Tetsuya Matsuura, Akiko Fuyuki, Hidenori Ohkubo, Atsushi Nakajima
Format:	Article
Language:	English
Published:	BMC 2020-08-01
Subjects:	Colorectal Cancer Chemoprevention Leukotriene receptor antagonist Aberrant crypt foci
Online Access:	http://link.springer.com/article/10.1186/s12885-020-07266-6